The role of PK/PD modeling and in silico approaches in drug development: A pharmaceutical industry perspective
Pharmacokinetic/pharmacodynamic (PK/PD) modeling and in silico approaches have become central to modern drug development, providing a quantitative framework for evidence-based decisions across non-clinical, translational, and clinical stages. Model-informed drug development integrates approaches such as population PK/P...